Erosive Oral Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Erosive Oral Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — “Erosive Oral Lichen Planus Global Clinical Trials Review, H1, 2016" provides an overview of Erosive Oral Lichen Planus clinical trials scenario. This report provides top line data relating to the clinical trials on Erosive Oral Lichen Planus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/403184-erosive-oral-lichen-planus-global-clinical-trials-review-h1-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Erosive Oral Lichen Planus to Mouth And Dental Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Erosive Oral Lichen Planus to Mouth And Dental Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Erosive Oral Lichen Planus Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71

Access Report @ https://www.wiseguyreports.com/reports/403184-erosive-oral-lichen-planus-global-clinical-trials-review-h1-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Leiomyosarcoma Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Leiomyosarcoma Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development for Leiomyosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/643484-leiomyosarcoma-pipeline-review-h2-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicationsDrug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global therapeutic landscape of Leiomyosarcoma
– The report reviews pipeline therapeutics for Leiomyosarcoma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Leiomyosarcoma therapeutics and enlists all their major and minor projects
– The report assesses Leiomyosarcoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Leiomyosarcoma

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Leiomyosarcoma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Leiomyosarcoma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Leiomyosarcoma Overview 7
Therapeutics Development 8
Pipeline Products for Leiomyosarcoma – Overview 8
Pipeline Products for Leiomyosarcoma – Comparative Analysis 9
Leiomyosarcoma – Therapeutics under Development by Companies 10
Leiomyosarcoma – Therapeutics under Investigation by Universities/Institutes 11
Leiomyosarcoma – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Leiomyosarcoma – Products under Development by Companies 14
Leiomyosarcoma – Products under Investigation by Universities/Institutes 15
Leiomyosarcoma – Companies Involved in Therapeutics Development 16
Advenchen Laboratories, LLC 16
BeiGene, Ltd. 17
Cell Medica Limited 18
Karyopharm Therapeutics, Inc. 19
Merck & Co., Inc. 20
Millennium Pharmaceuticals Inc 21
Mirati Therapeutics Inc. 22
Novartis AG 23
Pfizer Inc. 24
Vicore Pharma AB 25
Leiomyosarcoma – Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
AL-3818 – Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
axitinib – Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
BGB-290 – Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
C-21 – Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
Cellular Immunotherapy to Target LMP-1 and LMP-2 for Oncology and Infectious Diseases – Drug Profile 48
Product Description 48
Mechanism Of Action 48
R&D Progress 48
CMD-003 – Drug Profile 49
Product Description 49
Mechanism Of Action 49
R&D Progress 49
everolimus – Drug Profile 51
Product Description 51
Mechanism Of Action 51
R&D Progress 51

Access Report @ https://www.wiseguyreports.com/reports/643484-leiomyosarcoma-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Multi Factor Authentication Market 2016 Analysis and Forecast to 2021

MFA Market is expected to grow at a compound annual growth rate of 19.86% over the period to reach a total market size of US$10.953 billion by 202

PUNE, INDIA , November 11, 2016 /EINPresswire.com/ — Multi Factor Authentication Market

Multi-Factor Authentication (MFA) Market is expected to grow at a compound annual growth rate of 19.86% over the period to reach a total market size of US$10.953 billion by 2021, from US$3.694 billion in 2015. Multi-factor authentication helps in meeting the security requirements for the protection of sensitive and confidential information from unauthorized access. Government regulations to increase the security of the users serve as a key factor for the growth of the market. With the increase in online trading and transaction, there is a growing need to reduce financial fraud, data breach and phishing which can be successfully achieved by these authentication solutions. North America region accounted for the dominant share of this market in 2015 due to the presence of large institutions and companies, IT Infrastructure and increasing adoption of cloud services.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/646807-multi-factor-authentication-market-forecasts-from-2016-to-2021

Research Methodology

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of Multi-Factor Authentication. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Access Complete Report @ https://www.wiseguyreports.com/reports/646807-multi-factor-authentication-market-forecasts-from-2016-to-2021

Segmentation

Thirdly, Multi-Factor Authentication market has been segmented on the basis of Model and Application. Under model; Two-Factor Authentication, Three-Factor Authentication, Four-Factor Authentication and Five-Factor Authentication have been covered. Under application, the market is segmented into BFSI, Defense, Travel and Transport, among others. Detailed comprehensive forecast with analysis has also been covered as part of this section. Important regions for vendors in terms of market size are covered through detailed geographical segmentation. Geographical regions covered as a part of this section are Americas, Europe Middle East and Africa and Asia Pacific.

Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=646807

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of the part of this report are RSA, EMC Corporation, Entrust, Gemalto, Authentify, CA Technologies, HID Global, Deepnet Securities, Vasco along with others

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Daewoong Pharmaceutical Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Daewoong Pharmaceutical Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Daewoong Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/643488-daewoong-pharmaceutical-co-ltd-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Daewoong Pharmaceutical Co., Ltd.
– The report provides overview of Daewoong Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Daewoong Pharmaceutical Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Daewoong Pharmaceutical Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Daewoong Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Daewoong Pharmaceutical Co., Ltd.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Daewoong Pharmaceutical Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 6
Daewoong Pharmaceutical Co., Ltd. Snapshot 7
Daewoong Pharmaceutical Co., Ltd. Overview 7
Key Information 7
Key Facts 7
Daewoong Pharmaceutical Co., Ltd. – Research and Development Overview 8
Key Therapeutic Areas 8
Daewoong Pharmaceutical Co., Ltd. – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Pipeline Products – Combination Treatment Modalities 13
Daewoong Pharmaceutical Co., Ltd. – Pipeline Products Glance 14
Daewoong Pharmaceutical Co., Ltd. – Late Stage Pipeline Products 14
Pre-Registration Products/Combination Treatment Modalities 14
Phase III Products/Combination Treatment Modalities 15
Daewoong Pharmaceutical Co., Ltd. – Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
Daewoong Pharmaceutical Co., Ltd. – Early Stage Pipeline Products 18
Preclinical Products/Combination Treatment Modalities 18
Discovery Products/Combination Treatment Modalities 19
Daewoong Pharmaceutical Co., Ltd. – Drug Profiles 20
DWJ-1261 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
nepidermin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
onabotulinumtoxin A 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
(olmesartan medoxomil + rosuvastatin calcium) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
DWP-05195 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
DWC-20151 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
DWC-20152 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
DWP-09031 27
Product Description 27
Mechanism of Action 27
R&D Progress 27

Access Report @ https://www.wiseguyreports.com/reports/643488-daewoong-pharmaceutical-co-ltd-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here

Source: PR

Europe Middle East and Africa Print Labels Market Forecast to 2021


Europe Middle East and Africa Print Labels Market was estimated at US$12.227 billion in 2015 and will grow to US$15.003 billion by 2021, at a CAGR of 3.47%

PUNE, INDIA , November 11, 2016 /EINPresswire.com/ — Europe Middle East and Africa (EMEA) Print Labels Market

Europe Middle East and Africa (EMEA) Print Labels Market was estimated at US$12.227 billion in 2015 and will grow to US$15.003 billion by 2021, at a CAGR of 3.47% over the forecast period. Consumers in European countries are demanding innovative products which require coloured high-quality digital printing for more personalized offerings, thereby boosting the growth of print labels market. Increasing demand for packaged food and beverage products further fuels the demand for innovative and effective print labels in the region. However, high investment in the print labels industry is hindering the growth of print labels market, especially for the new entrants. Moreover, European converters are witnessing rising costs of raw materials which will also act as a restraint to the growth of this industry over the forecast period.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/646783-europe-middle-east-and-africa-emea-print-labels-market-forecasts-from-2016-to-2021

Research Methodology
The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics
Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry and regional regulations which are determining the product specifications and a brief technological aspect of print labels solutions. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Access Complete Report @ https://www.wiseguyreports.com/reports/646783-europe-middle-east-and-africa-emea-print-labels-market-forecasts-from-2016-to-2021

Segmentation
Thirdly, EMEA Print Labels market has been segmented on the basis of type, printing technology, end-use industry, and geography. By type, the market has been segmented as pressure sensitive labels, in-mold labels, wet-glued labels, sleeve labels, multi-part tracking labels, and others. By printing technology, segmentation has been done as flexography, offset, screen, letterpress, gravure, and digital. EMEA Print Labels market has further been segmented by end-use industry into healthcare, food and beverage, personal care, industrial, household care, consumer electronics, and others. By geography, the segmentation has been done as Europe (United Kingdom, Germany, Spain, Italy, France and others) and the Middle East and Africa.

Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=646783

Market Players
Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry participants profiled as part of this section are Mondi, Cenveo, CCL Industries, 3M and Bemis among others.

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

External Defibrillators Therapeutic and Overview Pipeline Review H2



Wise.Guy.

External Defibrillators Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segment – Professional Defibrillators.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/417092-united-states-external-defibrillators-market-outlook-to-one

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. Research uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
– Market size for External Defibrillators market segment – Professional Defibrillators.
– Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
– 2014 company shares and distribution shares data for External Defibrillators market.
– Global corporate-level profiles of key companies operating within the United States External Defibrillators market.
– Key players covered include Philips Healthcare, Zoll Medical Corporation, Physio-Control, Inc., Opto Circuits India Limited, Defibtech, LLC and Others.

Reasons to buy
– Develop business strategies by identifying the key market segments poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 External Defibrillators Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 External Defibrillators Market, United States 7
3.1 External Defibrillators Market, United States, Revenue ($m), 2007-2014 7
3.2 External Defibrillators Market, United States, Revenue ($m), 2014-2021 8
3.2.1 Professional Defibrillators Market, United States, Revenue ($m), by Segment, 2007-2014 9
3.2.2 Professional Defibrillators Market, United States, Revenue ($m), by Segment, 2014-2021 11
3.3 External Defibrillators Market, United States, Volume (Units), 2007-2014 13
3.4 External Defibrillators Market, United States, Volume (Units), 2014-2021 14
3.4.1 Professional Defibrillators Market, United States, Volume (Units), by Segment, 2007-2014 15
3.4.2 Professional Defibrillators Market, United States, Volume (Units), by Segment, 2014-2021 17
3.5 External Defibrillators Market, United States, Average Price ($), 2007-2021 19
3.6 External Defibrillators Market, United States, Distribution Share by Revenue ($m), 2013-2014 20
3.7 External Defibrillators Market, United States, Company Share by Revenue ($m), 2014 21
4 Overview of Key Companies in United States, External Defibrillators Market 23
4.1 Zoll Medical Corporation 23
4.1.1 Company Overview 23
4.2 Philips Healthcare 23
4.2.1 Company Overview 23
4.3 Physio-Control, Inc. 23
4.3.1 Company Overview 23
4.4 Opto Circuits India Limited 24
4.4.1 Company Overview 24
4.5 Schiller AG 24
4.5.1 Company Overview 24
4.6 Nihon Kohden Corporation 24
4.6.1 Company Overview 24
4.7 Defibtech, LLC 25
4.7.1 Company Overview 25
5 Appendix 26
5.1 Research Methodology 27
5.1.1 Coverage 27
5.1.2 Secondary Research 27
5.1.3 Primary Research 28
5.1.4 Market Modeling and Forecasting 29
5.1.5 Company Share Analysis 32
5.1.6 Distribution Share Analysis 33
5.2 Expert Panel 34

Access Report @ https://www.wiseguyreports.com/reports/417092-united-states-external-defibrillators-market-outlook-to-one

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Hand Tool Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report studies Hand Tool in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India

PUNE, MAHARASTRA, INDIA, November 11, 2016 /EINPresswire.com/ — Summary

This report studies Hand Tool in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Stanley Black & Decker
Ikea
Fehr Bros
Tangshan Shushi Hardware Tools
SGS Tool Company
Truper
Kora Amruta Industries
Zhangjiagang Scowell Hardware Tools
SUMEC Hardware & Tools

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/735424-global-hand-tool-market-research-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hand Tool in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Pliers
Knife
Ruler
Axe
Saw
Others
Split by application, this report focuses on consumption, market share and growth rate of Hand Tool in each application, can be divided into
Application 1
Application 2
Application 3

At any Query @ https://www.wiseguyreports.com/enquiry/735424-global-hand-tool-market-research-report-2016

Table of Contents

Global Hand Tool Market Research Report 2016
1 Hand Tool Market Overview
1.1 Product Overview and Scope of Hand Tool
1.2 Hand Tool Segment by Type
1.2.1 Global Production Market Share of Hand Tool by Type in 2015
1.2.2 Pliers
1.2.3 Knife
1.2.4 Ruler
1.2.5 Axe
1.2.6 Saw
1.2.7 Others
1.3 Hand Tool Segment by Application
1.3.1 Hand Tool Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Hand Tool Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Hand Tool (2011-2021)

7 Global Hand Tool Manufacturers Profiles/Analysis
7.1 Stanley Black & Decker
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Hand Tool Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Stanley Black & Decker Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Ikea
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Hand Tool Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Ikea Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Fehr Bros
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Hand Tool Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Fehr Bros Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Tangshan Shushi Hardware Tools
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Hand Tool Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Tangshan Shushi Hardware Tools Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 SGS Tool Company
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Hand Tool Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 SGS Tool Company Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Truper
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Hand Tool Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Truper Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Kora Amruta Industries
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Hand Tool Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Kora Amruta Industries Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Zhangjiagang Scowell Hardware Tools
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Hand Tool Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Zhangjiagang Scowell Hardware Tools Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 SUMEC Hardware & Tools
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Hand Tool Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 SUMEC Hardware & Tools Hand Tool Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735424

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Global Diamond Rings Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report studies Diamond Rings in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India

PUNE, MAHARASTRA, INDIA, November 11, 2016 /EINPresswire.com/ —

Summary

This report studies Diamond Rings in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Harry Winston (US)
Cartier (FR)
Tiffany (US)
Graff (UK)
Bvlgari (IT)
Van Cleef & Arpels (FR)
SWAROVSKI (AT)
Boucheron (FR)
Mikimoto (JP)
Derier (FR)
Damiani (IT)
Chow Sang Sang (CN)
Zhouliufu (CN)
TSL (CN)
Kimberlite (CN)
Chow Tai Seng (CN)

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/735415-global-diamond-rings-market-research-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Diamond Rings in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Diamond Rings in each application, can be divided into
Application 1
Application 2
Application 3

At any Query @ https://www.wiseguyreports.com/enquiry/735415-global-diamond-rings-market-research-report-2016

Table of Contents

Global Diamond Rings Market Research Report 2016
1 Diamond Rings Market Overview
1.1 Product Overview and Scope of Diamond Rings
1.2 Diamond Rings Segment by Type
1.2.1 Global Production Market Share of Diamond Rings by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Diamond Rings Segment by Application
1.3.1 Diamond Rings Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Diamond Rings Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Diamond Rings (2011-2021)

7 Global Diamond Rings Manufacturers Profiles/Analysis
7.1 Harry Winston (US)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Diamond Rings Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Harry Winston (US) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Cartier (FR)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Diamond Rings Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Cartier (FR) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Tiffany (US)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Diamond Rings Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Tiffany (US) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Graff (UK)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Diamond Rings Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Graff (UK) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Bvlgari (IT)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Diamond Rings Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Bvlgari (IT) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Van Cleef & Arpels (FR)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Diamond Rings Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Van Cleef & Arpels (FR) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 SWAROVSKI (AT)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Diamond Rings Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 SWAROVSKI (AT) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Boucheron (FR)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Diamond Rings Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Boucheron (FR) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Mikimoto (JP)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Diamond Rings Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Mikimoto (JP) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Derier (FR)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Diamond Rings Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Derier (FR) Diamond Rings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Damiani (IT)
7.12 Chow Sang Sang (CN)
7.13 Zhouliufu (CN)
7.14 TSL (CN)
7.15 Kimberlite (CN)
7.16 Chow Tai Seng (CN)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735415

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Asia Pacific Print Labels Market to Grow at a CAGR Of 6.69% to Forecast 2021

Asia Pacific Print Labels Market is estimated to grow from US$12.412 billion in 2015 to US$18.306 billion by 2021, at a CAGR of 6.69% over the forecast period.

PUNE, INDIA , November 11, 2016 /EINPresswire.com/ — Asia Pacific Print Labels Market

Asia Pacific Print Labels Market is estimated to grow from US$12.412 billion in 2015 to US$18.306 billion by 2021, at a CAGR of 6.69% over the forecast period. Due to continued rapid expansion of Chinese and Indian label demand, Asia Pacific Print Labels market will witness the fastest growth rate over the forecast period. High economic growth in emerging economies, rising disposable income and growing health awareness are some of the key factors augmenting the demand for packaged food and beverage products, which in turn has boosted the demand for print labels in the region. Booming ageing population, especially in Japan, has escalated the need for more healthcare services, coupled with the increased use of cosmaceuticals, is impacting the demand for print labels by end-use industries.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/646782-asia-pacific-print-labels-market-forecasts-from-2016-to-2021

Research Methodology
First section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics
Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry and regional regulations which are determining the product specifications and a brief technological aspect of print labels solutions. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.

Access Complete Report @ https://www.wiseguyreports.com/reports/646782-asia-pacific-print-labels-market-forecasts-from-2016-to-2021

Segmentation
Thirdly, Asia Pacific Print Labels market has been segmented on the basis of type, printing technology, end-use industry, and geography. By type, the market has been segmented as pressure sensitive labels, in-mold labels, wet-glued labels, sleeve labels, multi-part tracking labels, and others. By printing technology, segmentation has been done as flexography, offset, screen, letterpress, gravure, and digital. Asia Pacific Print Labels market has further been segmented by end-use industry as healthcare, food and beverage, personal care, industrial, household care, consumer electronics, and others. By geography, the segmentation has been done as China, Japan, India, South Korea, and others.

Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=646782

Market Players
Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key five industry participants profiled as part of this section are Mondi, Avery Dennison, CCL Industries, Innovia Films and Bemis.

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Osteosarcoma Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Osteosarcoma Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/643470-osteosarcoma-pipeline-review-h2-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global therapeutic landscape of Osteosarcoma
– The report reviews pipeline therapeutics for Osteosarcoma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Osteosarcoma therapeutics and enlists all their major and minor projects
– The report assesses Osteosarcoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Osteosarcoma

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Osteosarcoma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Osteosarcoma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Osteosarcoma Overview 11
Therapeutics Development 12
Pipeline Products for Osteosarcoma – Overview 12
Pipeline Products for Osteosarcoma – Comparative Analysis 13
Osteosarcoma – Therapeutics under Development by Companies 14
Osteosarcoma – Therapeutics under Investigation by Universities/Institutes 16
Osteosarcoma – Pipeline Products Glance 17
Clinical Stage Products 17
Early Stage Products 18
Osteosarcoma – Products under Development by Companies 19
Osteosarcoma – Products under Investigation by Universities/Institutes 20
Osteosarcoma – Companies Involved in Therapeutics Development 21
Advaxis, Inc. 21
Amgen Inc. 22
AVEO Pharmaceuticals, Inc. 23
Bayer AG 24
Bellicum Pharmaceuticals, Inc. 25
Celldex Therapeutics, Inc. 26
CytRx Corporation 27
Eleison Pharmaceuticals LLC 28
Exelixis, Inc. 29
Isofol Medical AB 30
MediaPharma s.r.l. 31
Merck & Co., Inc. 32
Merrimack Pharmaceuticals, Inc. 33
Netris Pharma S.A.S. 34
Novartis AG 35
Oncolys BioPharma Inc 36
Pfizer Inc. 37
Shionogi & Co., Ltd. 38
Teijin Pharma Limited 39
United Therapeutics Corporation 40
Osteosarcoma – Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Target 42
Assessment by Mechanism of Action 45
Assessment by Route of Administration 48
Assessment by Molecule Type 50
Drug Profiles 52
3D-QM – Drug Profile 52
Product Description 52
Mechanism Of Action 52
R&D Progress 52
3D-QMS – Drug Profile 53
Product Description 53
Mechanism Of Action 53
R&D Progress 53
ADXS-HER2 – Drug Profile 54
Product Description 54
Mechanism Of Action 54
R&D Progress 54
aldoxorubicin hydrochloride – Drug Profile 58
Product Description 58

Access Report @ https://www.wiseguyreports.com/reports/643470-osteosarcoma-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR